Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Various Options For Legacy Products Whose Conformity Assessment Certificates Have Expired

Executive Summary

How does the European Commission’s proposal to amend the Medical Device Regulation to extend the transition periods for legacy devices impact devices that may seem lost to the market? 

You may also be interested in...



Commenting On the EU MDR Proposal? What You Need To Know About Finer Details

18 January is the deadline to respond to the European Commission’s 6 January proposal to amend the Medical Device Regulation by extending legacy product transition deadlines. This article explains how changes are expected to be made.

European Commission Invites Comments On Its Critical MDR Proposal

The EU is looking at extending transition deadlines for compliance under the Medical Device Regulation as a matter of urgency. Now the European Commission is inviting feedback on its proposed measures.

Commission Adopts Proposal For EU MDR Changes, Sets Out New Transition Deadlines

The European Commission is now a step closer to implementing legislation that will see staggered delays for the application of the MDR in a bid to forestall medical devices shortages across the EU, with even longer extensions proposed than previously expected.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT147525

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel